Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...
| Автори: | , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Endocrinology Research Centre
2018-12-01
|
| Серія: | Ожирение и метаболизм |
| Предмети: | |
| Онлайн доступ: | https://www.omet-endojournals.ru/jour/article/view/9584 |